Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.

Respiratory investigation - 1 Mar 2012

Ishikawa Nobuhisa, Hattori Noboru, Yokoyama Akihito, Kohno Nobuoki

Abstract excerpt

Interstitial lung diseases (ILDs) are a diverse group of pulmonary disorders characterized by various patterns of inflammation and fibrosis in the interstitium of the lung. Because injury and/or regeneration of type II pneumocytes are prominent histological features of ILDs, substances derived from type II pneumocytes have been the focus of research investigating potential biomarkers for ILD. One important...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alveolar Epithelial Cells
Share to Biomarkers
Share to Forecasting

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Lung Diseases, Interstitial

Share to Mucin-1

Share to Racial Groups

Share to Regeneration

Source

Identifiers

PMID: 22554854
DOI: 10.1016/j.resinv.2012.02.001

Genes

MUC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.PMID 22554854Read ↗

Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels.Semantic proximity Read ↗

Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease.Semantic proximity Read ↗

Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease.Semantic proximity Read ↗

Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.Semantic proximity Read ↗

Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis.Semantic proximity Read ↗

Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome.Semantic proximity Read ↗

Salivate glycogen-6 expression and clinical significance in children with interstitial lung diseaseSemantic proximity Read ↗

Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation.Semantic proximity Read ↗

MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis.Semantic proximity Read ↗

Comparative Analysis of Clinical, Radiographic, and Serological Features Between CTD-ILD and IIPSemantic proximity Read ↗

Periostin: A Biomarker Useful in Treating Patients with Progressive Fibrosing Interstitial Lung DiseasesSemantic proximity Read ↗

The Association Between MUC5B Mutations and Clinical Outcome in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Retrospective Exploratory Study in China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.